Amneal Pharmaceuticals annual return on equity
2018
2019
2020
2021
2022
2023
Amneal Pharmaceuticals Return on Equity (ROE) Growth & History (AMRX)
Amneal Pharmaceuticals's return on equity was −52.79% for fiscal 2023.
View full Amneal Pharmaceuticals company overviewAmneal Pharmaceuticals annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2023 | 2023-12-31 | −52.79% | +29.36 pp |
| 2022 | 2022-12-31 | −82.15% | −86.12 pp |
| 2021 | 2021-12-31 | 3.97% | −21.36 pp |
| 2020 | 2020-12-31 | 25.33% | +189.17 pp |
| 2019 | 2019-12-31 | −163.85% | −156.02 pp |
| 2018 | 2018-12-31 | −7.82% | — |
Amneal Pharmaceuticals quarterly return on equity
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2023 | 2023-12-31 | −56.27% | −52.23 pp |
| Q3 2023 | 2023-09-30 | 2.98% | +5.62 pp |
| Q2 2023 | 2023-06-30 | 3.89% | +76.01 pp |
| Q1 2023 | 2023-03-31 | −2.34% | +0.00 pp |
| Q4 2022 | 2022-12-31 | −4.04% | +2.10 pp |
| Q3 2022 | 2022-09-30 | −2.64% | −0.40 pp |
| Q2 2022 | 2022-06-30 | −72.12% | −81.09 pp |
| Q1 2022 | 2022-03-31 | −2.35% | −6.42 pp |
| Q4 2021 | 2021-12-31 | −6.13% | −3.87 pp |
| Q3 2021 | 2021-09-30 | −2.23% | +4.90 pp |
| Q2 2021 | 2021-06-30 | 8.96% | +16.71 pp |
| Q1 2021 | 2021-03-31 | 4.07% | −39.69 pp |
| Q4 2020 | 2020-12-31 | −2.26% | +26.58 pp |
| Q3 2020 | 2020-09-30 | −7.13% | +71.08 pp |
| Q2 2020 | 2020-06-30 | −7.74% | −4.11 pp |
| Q1 2020 | 2020-03-31 | 43.76% | +53.56 pp |
| Q4 2019 | 2019-12-31 | −28.85% | −24.80 pp |
| Q3 2019 | 2019-09-30 | −78.21% | −79.60 pp |
| Q2 2019 | 2019-06-30 | −3.63% | +3.60 pp |
| Q1 2019 | 2019-03-31 | −9.80% | — |
| Q4 2018 | 2018-12-31 | −4.04% | — |
| Q3 2018 | 2018-09-30 | 1.38% | — |
| Q2 2018 | 2018-06-30 | −7.23% | — |
Amneal Pharmaceuticals return on equity trends
Over the last five fiscal years, Amneal Pharmaceuticals's return on equity decreased from −7.82% to −52.79%, a change of −44.97 percentage points. The latest reported quarter, Q4 2023, shows −56.27%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Amneal Pharmaceuticals source filings ↗